| Literature DB >> 26354761 |
Xi-Ping Yan1, He-He Liu1, Jun-Ying Liu1, Rong-Ping Zhang1, Guo-Song Wang1, Qing-Qing Li1, Ding-Min-Cheng Wang1, Liang Li1, Ji-Wen Wang2.
Abstract
Incubation temperature has an immediate and long-term influence on the embryonic development in birds. DNA methylation as an important environment-induced mechanism could serve as a potential link between embryos' phenotypic variability and temperature variation, which reprogrammed by DNA (cytosine-5)-methyltransferases (DNMTS) and Methyl-CpG binding domain proteins (MBPS) 3&5 (MBD3&5). Five genes in DNMTS and MBPS gene families were selected as target genes, given their important role in epigenetic modification. In this study, we aimed to test whether raising incubation temperature from 37.8°C to 38.8°C between embryonic days (ED) 1-10, ED10-20 and ED20-27 have effect on DNA methylation and whether DNMTS, MBPS play roles in thermal epigenetic regulation of early development in duck. Real-time quantitative PCR analysis showed that increased incubation temperature by 1°C has remarkably dynamic effect on gene expression levels of DNMTS and MBPS. Slight changes in incubation temperature significantly increased mRNA levels of target genes in breast muscle tissue during ED1-10, especially for DNMT1, DNMT3A and MBD5. In addition, higher temperature significantly increased enzyme activities of DNMT1 in leg muscle during ED10-20, liver tissue during ED1-10, ED20-27 and DNMT3A in leg muscle and breast muscle tissue during ED10-20. These results suggest that incubation temperature has an extended effect on gene expression levels and enzyme activities of DNMTS and MBPS, which provides evidence that incubation temperature may influence DNA methylation in duck during early developmental stages. Our data indicated that DNMTS and MBPS may involved in thermal epigenetice regulation of embryos during the early development in duck. The potential links between embryonic temperature and epigenetic modification need further investigation.Entities:
Keywords: DNA methylation; duck; embryonic period; incubation temperature
Mesh:
Year: 2015 PMID: 26354761 PMCID: PMC5011409 DOI: 10.3382/ps/pev201
Source DB: PubMed Journal: Poult Sci ISSN: 0032-5791 Impact factor: 3.352
Figure 1.The basic treatment process. CG, TG mean control group and treatment group. Treatment was comprised of increasing the incubation temperature by 1°C during ED1–10, ED10–20, ED20–27. means at ED10, more than 15 qualified eggs were transferred from control group to treatment group and incubated at 38.8°C during ED10–20, while eggs in control group still incubated at 37.8°C. means at ED20, more than 15 qualified eggs were transferred from control group to treatment group and incubated at 38.8°C during ED20–27, while eggs in control group still incubated at 37.8°C. Samples were taken at ED10, 20 and 27.
Primers for PCR analysis
| Gene | Primer sequence (5′-3′) | Product length(bp) | Tm(°C) | |
|---|---|---|---|---|
| dnmt1 | F | 5′-GCTATGTCGCCCTGGATTTC-3′ | 507 | 64.1 |
| R | 5′-CACAGGACTCCATACCCAAGAA-3′ | |||
| dnmt3a | F | 5′-GGAGCACCCTTTGTTTATCG-3′ | 481 | 56.8 |
| R | 5′-TTCGGAGGCAATGTAGCG-3′ | |||
| dnmt3b | F | 5′-CCACTACACCGACGTTTCCA-3′ | 443 | 60.3 |
| R | 5′-GCCTCCACCACTTTCTCCTC-3′ | |||
| mbd3 | F | 5′-TGGACCTCAGCACTTTCGAC-3′ | 387 | 61.6 |
| R | 5′-GCAGAGCACTAGCGATAGCA-3′ | |||
| mbd5 | F | 5′-GCTATGTCGCCCTGGATTTC-3′ | 525 | 63.5 |
| R | 5′-CACAGGACTCCATACCCAAGAA-3′ |
Notes: F, forward primer; R, reverse primer.
Primers for real-time PCR
| Gene | Primer sequence (5′-3′) | Product length(bp) | Tm(°C) | |
|---|---|---|---|---|
| β | F | 5′-GCTATGTCGCCCTGGATTTC-3′ | 168 | 60 |
| R | 5′-CACAGGACTCCATACCCAAGAA-3′ | |||
| GADPH | F | 5′-AAGGCTGAGAATGGGAAAC-3′ | 254 | 60 |
| R | 5′-TTCAGGGACTTGTCATACTTC-3′ | |||
| 18S rRNA | F | 5′-TTGGTGGAGCGATTTGTC-3′ | 129 | 60 |
| R | 5′-ATCTCGGGTGGCTGAACG-3′ | |||
| dnmt1 | F | 5′-GAAATCGACGGTCGTCTCCTC-3′ | 149 | 60 |
| R | 5′-TCAGCAACGGCAAGCCTAAC-3′ | |||
| dnmt3a | F | 5′-GAGGCAATGTAGCGATCCACC-3′ | 160 | 60 |
| R | 5′-CCAACAACCACGACCAGGAGT-3′ | |||
| dnmt3b | F | 5′-ACAGGCAAAGTAATCCTTGAGCG-3′ | 110 | 60 |
| R | 5′-CCGACGTTTCCAACATCAGC-3′ | |||
| mbd3 | F | 5′-ACCTTATTGCTGGGATGGTTTGT-3′ | 175 | 60 |
| R | 5′-GCACGGGAAAGATGTTGATGAG-3′ | |||
| mbd5 | F | 5′-GTTTCCATAGCCACCTCCTCC-3′ | 120 | 60 |
| R | 5′-TGTTTCTGCCATTGACACCACT-3′ |
Notes: F, forward primer; R, reverse primer.
Figure 2.Standard curve is used to determine DNMTS concentration in each sample. A. Standard curve of enzyme DNMT1 activity, B. Standard curve of enzyme DNMT3A activity, C. Standard curve of enzyme DNMT3B activity.
Figure 3.The relative mRNA expression levels of DNMTS and MBD3&5 in treatment and control groups (n = 6) were confirmed by real-time RCR. A. Relative gene expression of DNMT1, B. Relative gene expression of DNMT3A, C. Relative gene expression of DNMT3B, D. Relative gene expression of MBD3, E. Relative gene expression of MBD5. Label * on the bar means a significant difference at the level P < 0.05.
Figure 4.The enzyme activities of DNMTS in treatment and control groups (n = 6) were confirmed by DNMTS ELISA Kits. A. Determination of DNMT1 enzyme activity, B. Determination of DNMT3A enzyme activity, C. Determination of DNMT3B enzyme activity. Label * on the bar means a significant difference at the level P < 0.05.